Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

SCIENTISTS investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...

Discover the surprising link between herpes and Alzheimer's disease. Find out how the common herpes simplex virus may play a ...

The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

A sequence of stress signals among specialized clean-up cells in the brain could at last reveal why some immune responses can ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Alzheimer's is the most common cause of dementia and researchers say their findings could lead to treatments that could slow ...

China aims to have a sweeping action plan for dementia in place by 2030, encompassing all aspects of the disease, from ...